Schedule 13G ownership disclosure

aTyr Pharma Inc

Security class unavailable · CUSIP: 002120202

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,714,362
Percent of class
4.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-021596
Form type
SC 13G/A
Filer
Venrock Healthcare Capital Partners II, L.P.
CIK
CIK 1602264
Filed
Feb 14, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub